help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 72, No. 2 260-271
doi:10.1210/jcem-72-2-260
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KLING, M. A.
Right arrow Articles by GOLD, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLING, M. A.
Right arrow Articles by GOLD, P. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cushing's Syndrome
Hazardous Substances DB
*HYDROCORTISONE

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

MITCHEL A. KLING, ALEC ROY, R. DORAN, JOSEPH R. CALABRESE, DAVID R. RUBINOW, HARVEY J. DAVID, JR, CONRAD MAY, ROBERT M. POST, GEORGE P. CHROUSOS and PHILIP W. GOLD

Clinical Neuroendocrinology Branch (M.A.K., J.R.C., H.J.W., P.W.G.), Clinical Neurosciences Branch (A.R., A.R.D.), and Biological Psychiatry Branch (D.R.R., R.M.P.), National Institute of Mental Health; Laboratory of Neurosciences, National Institute on Aging (CM.); and Developmental Endocrinology Branch, National Institute of Child Health and Human Development (G.P.C.), National Institutes of Health Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Mitchel A. Kling, M.D., Chief, Unit on Affective Disorders, Clinical Neuroendocrinology Branch, National Institute on Mental Health/Division of Intramural Research Programs, National Institutes of Health Clinical Center, 9000 Rockville Pike, Building 10, Room 3S-231, Bethesda, Maryland 20892.

To explore whether possible differences in central nervous system neuromodulators contribute to the differential presentation of affective symptomatology in Cushing's disease and major depression, we examined the levels of immu-noreactive CRH and ACTH in the cerebrospinal fluid (CSF) of 11 patients with Cushing's disease, a patient with ectopic ACTH secretion, 34 patients with major depression, and 60 healthy subjects. We elected to measure these peptides not only because both are classically involved in pituitary-adrenal regulation, but also because their primarily arousal-producing and anorexigenic behavioral effects in experimental animals suggest that they may play a role in the symptom complex of depressive syndromes. We also explored whether the CSF levels of these peptides were more helpful in determining the often difficult differential diagnosis between major depression and Cushing's disease than the plasma ACTH response to ovine CRH, a currently used but somewhat insensitive laboratory means of distinguishing these disorders. CSF levels of immunoreactive CRH and ACTH were significantly lower in Cushing's disease patients [21.9 ± 2.7 and 15.4 ± 1.8 pg/mL, (mean ± SEM), respectively] compared to patients with major depression [38.4 ± 2.3 pg/mL (P < 0.01) and 5:4.5 ± 1.6 pg/mL (P < 0.01), respectively] and controls [38.4 ± 1.6 pg/mL (P < 0.001) and 26.3 ± 1.1 pg/mL (P < 0.001), respectively]. The coexistence of high plasma ACTH and low CSF ACTH in Cushing's disease yielded a CSF/plasma ACTH ratio consistently less than that in depressed patients, with only 2 of 31 subjects comprising both groups showing values that overlapped. In contrast, 9 of the combined patients showed ACTH responses to ovine CRH that overlapped. These data suggest that differences in centrally directed CRH secretion may account for the differential presentation of the dysphoric syndromes seen in major depression and Cushing's disease. Hence, the classic form of major depression (melancholia), is often associated with evidence of pathological hyperarousal, such as intense anxiety, sleeplessness, and anorexia, while that of Cushing's disease is associated with evidence of pathological hyposrousal, including hyperphagia, fatigue, and inertia. Moreover, measurement of the CSF/plasma ACTH ratio may serve as a clinically useful adjunct to the ovine CRH stimulation test and other laboratory measures in determining the differential diagnosis between major depression and Cushing's disease.

Received April 23, 1990.




This article has been cited by other articles:


Home page
NeuroscientistHome page
M. Mazza, M. Di Nicola, G. D. Marca, L. Janiri, P. Bria, and S. Mazza
Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions
Neuroscientist, August 1, 2007; 13(4): 392 - 404.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. M. Buckley and A. F. Schatzberg
On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3106 - 3114.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. P. Merke, J. N. Giedd, M. F. Keil, S. L. Mehlinger, E. A. Wiggs, S. Holzer, E. Rawson, A. C. Vaituzis, C. A. Stratakis, and G. P. Chrousos
Children Experience Cognitive Decline Despite Reversal of Brain Atrophy One Year After Resolution of Cushing Syndrome
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2531 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Merali, L. Du, P. Hrdina, M. Palkovits, G. Faludi, M. O. Poulter, and H. Anisman
Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region
J. Neurosci., February 11, 2004; 24(6): 1478 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z.'e. Hochberg, K. Pacak, and G. P. Chrousos
Endocrine Withdrawal Syndromes
Endocr. Rev., August 1, 2003; 24(4): 523 - 538.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. M. Strome, G. H. T. Wheler, J. D. Higley, D. L. Loriaux, S. J. Suomi, and D. J. Doudet
Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates
PNAS, November 26, 2002; 99(24): 15749 - 15754.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
R. C. Daly, T.-P. Su, P. J. Schmidt, D. Pickar, D. L. Murphy, and D. R. Rubinow
Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary Findings
Arch Gen Psychiatry, February 1, 2001; 58(2): 172 - 177.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, M. A. Kling, P. J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I. E. McCutcheon, T. D. Geracioti Jr., M. D. DeBellis, et al.
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
PNAS, January 4, 2000; 97(1): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
O. M. Wolkowitz and V. I. Reus
Treatment of Depression With Antiglucocorticoid Drugs
Psychosom Med, September 1, 1999; 61(5): 698 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. P. Chrousos and P. W. Gold
A Healthy Body in a Healthy Mind--and Vice Versa--The Damaging Power of "Uncontrollable" Stress
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1842 - 1845.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Yanovski, L. K. Nieman, J. L. Doppman, G. P. Chrousos, R. L. Wilder, P. W. Gold, and K. T. Kalogeras
Plasma Levels of Corticotropin-Releasing Hormone in the Inferior Petrosal Sinuses of Healthy Volunteers, Patients with Cushing's Syndrome, and Patients with Pseudo-Cushing States
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1485 - 1488.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. P. Chrousos
Editorial: Ultradian, Circadian, and Stress-Related Hypothalamic-Pituitary-Adrenal Axis Activity--A Dynamic Digital-to-Analog Modulation
Endocrinology, February 1, 1998; 139(2): 437 - 440.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos
The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. Virkkunen, R. Rawlings, R. Tokola, R. E. Poland, A. Guidotti, C. Nemeroff, G. Bissette, K. Kalogeras, S.-L. Karonen, and M. Linnoila
CSF Biochemistries, Glucose Metabolism, and Diurnal Activity Rhythms in Alcoholic, Violent Offenders, Fire Setters, and Healthy Volunteers
Arch Gen Psychiatry, January 1, 1994; 51(1): 20 - 27.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
E. M. Sternberg, G. P. Chrousos, R. L. Wilder, and P. W. Gold
The Stress Response and the Regulation of Inflammatory Disease
Ann Intern Med, November 15, 1992; 117(10): 854 - 866.
[Abstract] [PDF]


Home page
JAMAHome page
G. P. Chrousos and P. W. Gold
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
JAMA, March 4, 1992; 267(9): 1244 - 1252.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society